82 related articles for article (PubMed ID: 24670458)
41. Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer.
Aoki Y; Watanabe M; Amikura T; Obata H; Sekine M; Yahata T; Fujita K; Tanaka K
Gynecol Oncol; 2004 Aug; 94(2):333-9. PubMed ID: 15297170
[TBL] [Abstract][Full Text] [Related]
42. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418
[TBL] [Abstract][Full Text] [Related]
43. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
[TBL] [Abstract][Full Text] [Related]
44. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
[TBL] [Abstract][Full Text] [Related]
45. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
46. 20 year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: impact of treatment period and concurrent chemotherapy.
Song S; Song C; Kim HJ; Wu HG; Kim JH; Park NH; Song YS; Kim JW; Kang SB; Ha SW
Gynecol Oncol; 2012 Jan; 124(1):63-7. PubMed ID: 22004904
[TBL] [Abstract][Full Text] [Related]
47. [Identification of low-risk indicators of early stage cervical cancer].
Liu Q; Yang JX; Cao DY; Shen K; Wu M; Pan LY; Xiang Y; Lang JH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):580-4. PubMed ID: 23286402
[TBL] [Abstract][Full Text] [Related]
48. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
[TBL] [Abstract][Full Text] [Related]
49. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
[TBL] [Abstract][Full Text] [Related]
50. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
51. Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival.
Kasuya G; Ogawa K; Iraha S; Nagai Y; Hirakawa M; Toita T; Kakinohana Y; Kudaka W; Inamine M; Ariga T; Aoki Y; Murayama S
Anticancer Res; 2013 May; 33(5):2199-204. PubMed ID: 23645776
[TBL] [Abstract][Full Text] [Related]
52. [Analysis of prognostic factors in 159 cases of cervical adenocarcinoma].
Li H; Zhang WH; Zhang R; Wu LY; Li XG; Bai P
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):235-8. PubMed ID: 15924668
[TBL] [Abstract][Full Text] [Related]
53. Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up.
Luvero D; Plotti F; Aloisi A; Capriglione S; Ricciardi R; Miranda A; Lopez S; Scaletta G; De Luca G; Benedetti-Panici P; Angioli R
Med Oncol; 2016 Oct; 33(10):110. PubMed ID: 27577931
[TBL] [Abstract][Full Text] [Related]
54. Central nervous system gangliogliomas. Part 2: Clinical outcome.
Lang FF; Epstein FJ; Ransohoff J; Allen JC; Wisoff J; Abbott IR; Miller DC
J Neurosurg; 1993 Dec; 79(6):867-73. PubMed ID: 8246055
[TBL] [Abstract][Full Text] [Related]
55. The prognosis of "sandwich" mode of postoperative chemotherapy and radiation in patients with locally advanced cervical cancer.
Geng Y; Wang M; Yang S; Zhao H; Wu Y
J Obstet Gynaecol Res; 2022 Jan; 48(1):215-221. PubMed ID: 34664341
[TBL] [Abstract][Full Text] [Related]
56. Utilization and outcomes of adjuvant systemic chemotherapy alone in high risk, early stage cervical cancer in the United States.
Matsuo K; Nusbaum DJ; Matsuzaki S; Klar M; Shimada M; Takekuma M; Roman LD
Int J Gynecol Cancer; 2021 Jul; 31(7):991-1000. PubMed ID: 34016702
[TBL] [Abstract][Full Text] [Related]
57. [Clinical Analysis of Surgery for Recurrent Cervical Cancer: A Review of 45 Cases].
Han Y; Wu LY; Li N; Li XG; Zhang R; Sun YC
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):369-373. PubMed ID: 28535655
[No Abstract] [Full Text] [Related]
58. Revisiting Milan cervical cancer study: Do the original findings hold in the era of chemotherapy?
Ross Green W; Hathout L; Khan AJ; Elshaikh MA; Beriwal S; Small W; Mahmoud O
Gynecol Oncol; 2017 Feb; 144(2):299-304. PubMed ID: 27899201
[TBL] [Abstract][Full Text] [Related]
59. [Diagnosis, treatment and prognosis of neuroendocrine carcinoma of the colorectum].
Zhang YC; Zhuang J; Han GS; Wang JB
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Dec; 14(12):955-7. PubMed ID: 22205457
[TBL] [Abstract][Full Text] [Related]
60. Tumor Size Has a Time-Varying Effect on Recurrence in Cervical Cancer.
Chang C; Chen J; Chang WY; Chiang AJ
J Low Genit Tract Dis; 2016 Oct; 20(4):317-20. PubMed ID: 27438585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
